133 related articles for article (PubMed ID: 23459080)
41. Association of IGF1R polymorphisms with the development of HBV-related hepatocellular carcinoma.
Xie HY; Xing CY; Wei BJ; Xu X; Wu J; Chen LM; Cao GQ; Chen H; Chen KJ; Yin SY; Wu LM; Zhou L; Zheng SS
Tissue Antigens; 2014 Sep; 84(3):264-70. PubMed ID: 24758241
[TBL] [Abstract][Full Text] [Related]
42. Correlation between interleukin‑23 receptor gene polymorphisms and risk of hepatitis B virus infection in patients.
Peng Q; Qin Y; Chen Z; Deng Y; Xu J; Li S; Qin X
Mol Med Rep; 2013 Aug; 8(2):613-20. PubMed ID: 23807368
[TBL] [Abstract][Full Text] [Related]
43. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
44. The 14bp-deletion allele in the HLA-G gene confers susceptibility to the development of hepatocellular carcinoma in the Brazilian population.
Teixeira AC; Mendes-Junior CT; Souza FF; Marano LA; Deghaide NH; Ferreira SC; Mente ED; Sankarankutty AK; Elias-Junior J; Castro-e-Silva O; Donadi EA; Martinelli AL
Tissue Antigens; 2013 Jun; 81(6):408-13. PubMed ID: 23506091
[TBL] [Abstract][Full Text] [Related]
45. Role of leptin receptor (LEPR) gene polymorphisms and haplotypes in susceptibility to hepatocellular carcinoma in subjects with chronic hepatitis B virus infection.
Li Z; Yuan W; Ning S; Li J; Zhai W; Zhang S
Mol Diagn Ther; 2012 Dec; 16(6):383-8. PubMed ID: 23090836
[TBL] [Abstract][Full Text] [Related]
46. A trivial role of STAT4 variant in chronic hepatitis B induced hepatocellular carcinoma.
Clark A; Gerlach F; Tong Hv; Hoan NX; Song le H; Toan NL; Bock CT; Kremsner PG; Velavan TP
Infect Genet Evol; 2013 Aug; 18():257-61. PubMed ID: 23748017
[TBL] [Abstract][Full Text] [Related]
47. IL-6(-572/-597) polymorphism and expression in HBV disease chronicity in an Indian population.
Saxena R; Chawla YK; Verma I; Kaur J
Am J Hum Biol; 2014; 26(4):549-55. PubMed ID: 24841049
[TBL] [Abstract][Full Text] [Related]
48. Interleukin-1 polymorphism and expression in hepatitis B virus-mediated disease outcome in India.
Saxena R; Chawla YK; Verma I; Kaur J
J Interferon Cytokine Res; 2013 Feb; 33(2):80-9. PubMed ID: 23210983
[TBL] [Abstract][Full Text] [Related]
49. Association of human leukocyte antigen class I polymorphism with spontaneous clearance of hepatitis B surface antigen in Qidong Han population.
Miao F; Sun H; Pan N; Xu J; Qiu J; Shen Y; Xie W; Zhang J
Clin Dev Immunol; 2013; 2013():145725. PubMed ID: 24324503
[TBL] [Abstract][Full Text] [Related]
50. The genetic polymorphism down-regulating HLA-DRB1 enhancer activity facilitates HBV persistence, evolution and hepatocarcinogenesis in the Chinese Han population.
Deng Y; Li P; Liu W; Pu R; Yang F; Song J; Yin J; Han X; Li C; Zhao J; Wang H; Cao G
J Viral Hepat; 2020 Nov; 27(11):1150-1161. PubMed ID: 32568442
[TBL] [Abstract][Full Text] [Related]
51. HLA Zygosity Increases Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Liu Z; Huang CJ; Huang YH; Pan MH; Lee MH; Yu KJ; Pfeiffer RM; Viard M; Yuki Y; Gao X; Carrington M; Chen CJ; Hildesheim A; Yang HI;
J Infect Dis; 2021 Nov; 224(10):1796-1805. PubMed ID: 33852009
[TBL] [Abstract][Full Text] [Related]
52. Human leukocyte antigen class I association with occult hepatitis B virus infection in the Shaanxi Han group: Analysis at the haplotype level.
Wang T; Qi J; Li H; Chen L; Liu S; Shen C
J Gene Med; 2022 Jan; 24(1):e3393. PubMed ID: 34643983
[TBL] [Abstract][Full Text] [Related]
53. Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma.
Lin YY; Yu MW; Lin SM; Lee SD; Chen CL; Chen DS; Chen PJ
Cancer; 2017 Oct; 123(20):3966-3976. PubMed ID: 28662289
[TBL] [Abstract][Full Text] [Related]
54. A missense polymorphism in ATF6 gene is associated with susceptibility to hepatocellular carcinoma probably by altering ATF6 level.
Wu X; Xin Z; Zhang W; Zheng S; Wu J; Chen K; Wang H; Zhu X; Li Z; Duan Z; Li H; Liu Y
Int J Cancer; 2014 Jul; 135(1):61-8. PubMed ID: 24302549
[TBL] [Abstract][Full Text] [Related]
55. [Correlation between polymorphisms in the human leukocyte antigen-DQB1 alleles and hepatitis B with primary hepatocellular carcinoma].
Li Q; Li X; Zhang L; Zhao L
Zhonghua Gan Zang Bing Za Zhi; 2015 Apr; 23(4):270-4. PubMed ID: 26133818
[TBL] [Abstract][Full Text] [Related]
56. Human leukocyte antigen (HLA) class II association in chronic hepatitis B patients with hepatocellular carcinoma in a Malay population: A pilot study.
Krishnan PB; Abdullah M; Hudu SA; Sekawi Z; Tan SS; Amin-Nordin S
Trop Biomed; 2019 Sep; 36(3):703-708. PubMed ID: 33597492
[TBL] [Abstract][Full Text] [Related]
57. Host genetic variants influencing the clinical course of hepatitis B virus infection.
Matsuura K; Isogawa M; Tanaka Y
J Med Virol; 2016 Mar; 88(3):371-9. PubMed ID: 26255971
[TBL] [Abstract][Full Text] [Related]
58. Genome-wide association study: new genetic insights into HBV/HCV-related hepatocellular carcinoma genomes.
Zhu H; Wu J; Shen X
Scand J Gastroenterol; 2017 Feb; 52(2):209-215. PubMed ID: 27797287
[TBL] [Abstract][Full Text] [Related]
59. Interferon-stimulated gene 15 in hepatitis B-related liver diseases.
Hoan NX; Van Tong H; Giang DP; Toan NL; Meyer CG; Bock CT; Kremsner PG; Song LH; Velavan TP
Oncotarget; 2016 Oct; 7(42):67777-67787. PubMed ID: 27626177
[TBL] [Abstract][Full Text] [Related]
60. Contribution of an Asian-prevalent HLA haplotype to the risk of HBV-related hepatocellular carcinoma.
Kawamura A; Matsuda K; Murakami Y; Saruta M; Kohno T; Shiraishi K
Sci Rep; 2023 Aug; 13(1):12944. PubMed ID: 37558689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
